BRIEF-Tempest Reports Year End 2025 Financial Results And Provides Business Update

Reuters03-30
BRIEF-Tempest Reports Year End 2025 Financial Results And Provides Business Update

March 30 (Reuters) - Tempest Therapeutics Inc TPST.O:

  • TEMPEST REPORTS YEAR END 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

  • TEMPEST THERAPEUTICS INC - APPOINTS MATT ANGEL AS CEO AND PRESIDENT

  • TEMPEST THERAPEUTICS INC - ANNOUNCES POSITIVE INTERIM DATA FROM REDEEM-1 PHASE 1/2A TRIAL OF TPST-2003

  • TEMPEST THERAPEUTICS INC - REPORTS NET LOSS OF $26.3 MILLION AND NET LOSS PER SHARE OF $6.33 FOR 2025

Source text: ID:nGNX54qKQ6

Further company coverage: TPST.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment